TECTONIC THERAPEUTIC, INC. Investment Income, Net
TECTONIC THERAPEUTIC, INC. (TECX) reported Investment Income, Net of $1.15 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2024-05-09
- TECTONIC THERAPEUTIC, INC. investment income, net for the quarter ending 2024-03-31 was $1.15M, a 362.10% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. investment income, net for the quarter ending 2023-12-31 was $1.26M, a 414.29% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. investment income, net for the quarter ending 2023-09-30 was $1.41M, a 1167.57% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. investment income, net for the quarter ending 2023-06-30 was -$495.00K.
- TECTONIC THERAPEUTIC, INC. investment income, net for fiscal 2023 was $2.42M.
- TECTONIC THERAPEUTIC, INC. investment income, net for fiscal 2022 was -$299.00K.
- TECTONIC THERAPEUTIC, INC. investment income, net for fiscal 2021 was -$224.00K, a 131.15% decline from fiscal 2020.
- TECTONIC THERAPEUTIC, INC. investment income, net for fiscal 2020 was $719.00K.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2024-03-31 | $1.15M 10-Q · filed 2024-05-09 | $2.41M derived: sum of 2 quarters · filed 2024-05-09 | $3.81M derived: sum of 3 quarters · filed 2024-05-09 | $3.32M derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $2.67M derived: sum of 2 quarters · filed 2024-03-14 | $2.17M derived: sum of 3 quarters · filed 2024-03-14 | $2.42M 10-K · filed 2024-03-14 |
| 2023-09-30 | $1.41M 10-Q · filed 2023-11-09 | $912.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.16M 10-Q · filed 2023-11-09 | $1.41M derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-06-30 | -$495.00K 10-Q · filed 2023-08-10 | -$247.00K 10-Q · filed 2023-08-10 | -$2.00K derived: sum of 3 quarters · filed 2024-05-09 | $109.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-03-31 | $248.00K 10-Q · filed 2024-05-09 | $493.00K derived: sum of 2 quarters · filed 2024-05-09 | $604.00K derived: sum of 3 quarters · filed 2024-05-09 | $319.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $245.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $356.00K derived: sum of 2 quarters · filed 2024-03-14 | $71.00K derived: sum of 3 quarters · filed 2024-03-14 | -$299.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | $111.00K 10-Q · filed 2023-11-09 | -$174.00K derived: sum of 2 quarters · filed 2023-11-09 | -$544.00K 10-Q · filed 2023-11-09 | -$789.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$285.00K 10-Q · filed 2023-08-10 | -$655.00K 10-Q · filed 2023-08-10 | -$900.00K derived: sum of 3 quarters · filed 2023-08-10 | -$898.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$370.00K 10-Q · filed 2023-05-11 | -$615.00K derived: sum of 2 quarters · filed 2023-05-11 | -$613.00K derived: sum of 3 quarters · filed 2023-05-11 | -$604.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$245.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$243.00K derived: sum of 2 quarters · filed 2023-03-23 | -$234.00K derived: sum of 3 quarters · filed 2023-03-23 | -$224.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $2.00K 10-Q · filed 2022-11-08 | $11.00K derived: sum of 2 quarters · filed 2022-11-08 | $21.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $9.00K 10-Q · filed 2022-08-09 | $19.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $10.00K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $719.00K 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |